JBIO Jade Biosciences, Inc.
Nasdaq · SEC CIK 1798749 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 184 since 2021-07-01, latest 2026-06-26 21:20
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Balta Elizabeth | See Remarks | — | — |
| Frohlich Tom | CEO, Dir | — | — |
| King Andrew James | See Remarks | — | — |
| Dahms Bradford D. | CFO | — | — |
| Fairmount Healthcare Fund II L.P. | Dir, 10% | — | — |
Transactions 208
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-13 | 2026-02-12 | JBIO | Balta Elizabeth | See Remarks | A - Grant | $0.00 | +28.1K | 28.1K | New | $0 |
| D | 2026-02-13 | 2026-02-12 | JBIO | King Andrew James | See Remarks | A - Grant | $0.00 | +41.2K | 386.1K | +12% | $0 |
| D | 2026-02-13 | 2026-02-12 | JBIO | Frohlich Tom | CEO, Dir | A - Grant | $0.00 | +78.8K | 86.3K | +1,039% | $0 |
| D | 2026-02-13 | 2026-02-12 | JBIO | Dahms Bradford D. | CFO | A - Grant | $0.00 | +37.8K | 37.8K | New | $0 |
| DI | 2025-10-08 | 2025-10-06 | JBIO | Fairmount Healthcare Fund II L.P. | Dir, 10% | A - Grant | $9.14 | +1.33M | 1.90M | +236% | +$12.18M |
| 2025-05-19 | 2025-05-16 | JBIO | Frohlich Tom | CEO, Dir | P - Purchase | $7.40 | +6,000 | 6,000 | New | +$44.4K | |
| I | 2025-04-30 | 2025-04-28 | JBIO | Kolchinsky Peter | 10% | J - Other | — | +1.06M | 1.29M | +471% | — |
| DM | 2024-08-02 | 2024-07-31+ | JBIO | Dake Benjamin T | SEE REMARKS | M - OptEx | $1.74 | +13.0K | 14.3K | +1,004% | +$22.6K |
| I | 2024-06-20 | 2024-06-17 | JBIO | Shah Rajeev M. | Dir, 10% | P - Purchase | $1.67 | +928.1K | 7.89M | +13% | +$1.55M |
| D | 2024-06-14 | 2024-06-13 | JBIO | Gillies Hunter | Chief MEDICAL Off | S - Sale+OE | $24.50 | -6,000 | 5,602 | -52% | -$147.0K |
| D | 2024-06-14 | 2024-06-13 | JBIO | Gillies Hunter | Chief MEDICAL Off | M - OptEx | $2.14 | +6,000 | 11.6K | +107% | +$12.8K |
| D | 2024-06-14 | 2024-06-14 | JBIO | Verwijs Marinus | Chief TECHNICAL Off | S - Sale+OE | $25.00 | -10.6K | 0 | -100% | -$265.0K |
| D | 2024-06-14 | 2024-06-14 | JBIO | Verwijs Marinus | Chief TECHNICAL Off | M - OptEx | $14.59 | +10.6K | 10.6K | New | +$154.7K |
| D | 2024-06-14 | 2024-06-14 | JBIO | Eldridge George A | SEE REMARKS | S - Sale+OE | $25.03 | -15.0K | 5,022 | -75% | -$375.4K |
| D | 2024-06-14 | 2024-06-14 | JBIO | Eldridge George A | SEE REMARKS | M - OptEx | $2.14 | +15.0K | 20.0K | +299% | +$32.1K |
| DM | 2024-05-17 | 2024-05-17 | JBIO | Gillies Hunter | Chief MEDICAL Off | S - Sale+OE | $21.09 | -4,000 | 5,688 | -41% | -$84.3K |
| D | 2024-05-17 | 2024-05-17 | JBIO | Gillies Hunter | Chief MEDICAL Off | M - OptEx | $2.14 | +4,000 | 9,602 | +71% | +$8,560 |
| D | 2024-05-17 | 2024-05-16 | JBIO | NOYES TIMOTHY P | CEO, Dir | M - OptEx | $2.14 | +10.0K | 10.0K | New | +$21.4K |
| DM | 2024-05-17 | 2024-05-16 | JBIO | NOYES TIMOTHY P | CEO, Dir | S - Sale+OE | $21.57 | -10.0K | 1,293 | -89% | -$215.7K |
| 2024-05-03 | 2024-05-02 | JBIO | Verwijs Marinus | Chief TECHNICAL Off | S - Sale | $21.02 | -1,981 | 0 | -100% | -$41.6K | |
| D | 2024-05-03 | 2024-05-01 | JBIO | NOYES TIMOTHY P | CEO, Dir | M - OptEx | $2.14 | +10.0K | 10.0K | New | +$21.4K |
| DM | 2024-05-03 | 2024-05-01 | JBIO | NOYES TIMOTHY P | CEO, Dir | S - Sale+OE | $20.33 | -11.4K | 0 | -100% | -$230.9K |
| DM | 2024-04-19 | 2024-04-17 | JBIO | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $22.38 | -6,853 | 1,359 | -83% | -$153.4K |
| D | 2024-04-19 | 2024-04-17 | JBIO | Dake Benjamin T | SEE REMARKS | M - OptEx | $2.14 | +6,853 | 8,144 | +531% | +$14.7K |
| DM | 2024-04-19 | 2024-04-17 | JBIO | Gillies Hunter | Chief MEDICAL Off | S - Sale+OE | $22.38 | -4,000 | 3,562 | -53% | -$89.5K |
| D | 2024-04-19 | 2024-04-17 | JBIO | Gillies Hunter | Chief MEDICAL Off | M - OptEx | $1.74 | +4,000 | 7,251 | +123% | +$6,960 |
| DM | 2024-04-18 | 2024-04-16 | JBIO | NOYES TIMOTHY P | CEO, Dir | S - Sale+OE | $24.70 | -10.0K | 5,509 | -64% | -$247.0K |
| D | 2024-04-18 | 2024-04-16 | JBIO | NOYES TIMOTHY P | CEO, Dir | M - OptEx | $2.14 | +10.0K | 10.0K | New | +$21.4K |
| DM | 2024-04-12 | 2024-04-10 | JBIO | Eldridge George A | SEE REMARKS | S - Sale+OE | $26.85 | -7,500 | 2,731 | -73% | -$201.4K |
| D | 2024-04-12 | 2024-04-10 | JBIO | Eldridge George A | SEE REMARKS | M - OptEx | $2.14 | +7,500 | 9,460 | +383% | +$16.1K |
| I | 2024-04-11 | 2024-04-09 | JBIO | GRAYZEL DAVID S. | Dir | S - Sale | $28.15 | -11.9K | 14.5K | -45% | -$334.5K |
| D | 2024-04-03 | 2024-04-01 | JBIO | Eldridge George A | SEE REMARKS | M - OptEx | $2.14 | +12.5K | 14.5K | +638% | +$26.7K |
| D | 2024-04-03 | 2024-04-01 | JBIO | Eldridge George A | SEE REMARKS | S - Sale+OE | $31.23 | -12.5K | 1,960 | -86% | -$390.2K |
| DM | 2024-04-03 | 2024-04-01 | JBIO | NOYES TIMOTHY P | CEO, Dir | S - Sale+OE | $30.00 | -10.0K | 3,851 | -72% | -$300.0K |
| D | 2024-04-03 | 2024-04-01 | JBIO | NOYES TIMOTHY P | CEO, Dir | M - OptEx | $2.14 | +10.0K | 10.0K | New | +$21.4K |
| D | 2024-04-03 | 2024-04-01 | JBIO | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $31.97 | -3,325 | 1,291 | -72% | -$106.3K |
| D | 2024-04-03 | 2024-04-01 | JBIO | Dake Benjamin T | SEE REMARKS | M - OptEx | $10.61 | +3,325 | 4,616 | +258% | +$35.3K |
| DM | 2024-04-03 | 2024-04-01 | JBIO | Verwijs Marinus | Chief TECHNICAL Off | S - Sale+OE | $29.19 | -5,300 | 0 | -100% | -$154.7K |
| D | 2024-04-03 | 2024-04-01 | JBIO | Verwijs Marinus | Chief TECHNICAL Off | M - OptEx | $14.59 | +5,300 | 5,300 | New | +$77.3K |
| D | 2024-04-01 | 2024-03-28 | JBIO | Gillies Hunter | Chief MEDICAL Off | S - Sale+OE | $29.50 | -9,000 | 3,251 | -73% | -$265.5K |
| D | 2024-04-01 | 2024-03-28 | JBIO | Gillies Hunter | Chief MEDICAL Off | M - OptEx | $2.14 | +9,000 | 12.3K | +277% | +$19.3K |
| D | 2024-03-28 | 2024-03-27 | JBIO | Dake Benjamin T | SEE REMARKS | M - OptEx | $10.61 | +11.1K | 12.4K | +857% | +$117.4K |
| D | 2024-03-28 | 2024-03-27 | JBIO | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $27.97 | -11.1K | 1,291 | -90% | -$309.6K |
| D | 2024-03-27 | 2024-03-25 | JBIO | Dake Benjamin T | SEE REMARKS | M - OptEx | $10.61 | +3,432 | 4,723 | +266% | +$36.4K |
| D | 2024-03-27 | 2024-03-25 | JBIO | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $28.01 | -3,432 | 1,291 | -73% | -$96.1K |
| DM | 2024-03-20 | 2024-03-18 | JBIO | Gillies Hunter | Chief MEDICAL Off | S - Sale+OE | $25.86 | -7,000 | 3,251 | -68% | -$181.0K |
| DM | 2024-03-20 | 2024-03-18 | JBIO | Gillies Hunter | Chief MEDICAL Off | M - OptEx | $1.91 | +7,000 | 7,251 | +2,789% | +$13.4K |
| DM | 2024-03-20 | 2024-03-18 | JBIO | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $25.90 | -35.1K | 8,872 | -80% | -$908.0K |
| DM | 2024-03-20 | 2024-03-18 | JBIO | Dake Benjamin T | SEE REMARKS | M - OptEx | $5.64 | +35.1K | 21.8K | New | +$197.8K |
| DM | 2024-03-20 | 2024-03-19 | JBIO | Verwijs Marinus | Chief TECHNICAL Off | S - Sale+OE | $26.09 | -5,300 | 0 | -100% | -$138.3K |
| D | 2024-03-20 | 2024-03-19 | JBIO | Verwijs Marinus | Chief TECHNICAL Off | M - OptEx | $14.59 | +5,300 | 5,300 | New | +$77.3K |
| DM | 2024-03-14 | 2024-03-12+ | JBIO | Eldridge George A | SEE REMARKS | S - Sale+OE | $25.04 | -4,067 | 1,960 | -67% | -$101.8K |
| DM | 2024-03-14 | 2024-03-12+ | JBIO | Eldridge George A | SEE REMARKS | M - OptEx | $2.14 | +4,067 | 3,976 | New | +$8,703 |
| D | 2024-03-11 | 2024-03-07 | JBIO | Gillies Hunter | Chief MEDICAL Off | S - Sale+OE | $24.50 | -8,975 | 3,251 | -73% | -$219.9K |
| D | 2024-03-11 | 2024-03-07 | JBIO | Gillies Hunter | Chief MEDICAL Off | M - OptEx | $2.14 | +8,975 | 12.2K | +276% | +$19.2K |
| DM | 2024-03-11 | 2024-03-07+ | JBIO | Eldridge George A | SEE REMARKS | M - OptEx | $2.14 | +25.9K | 5,393 | New | +$55.5K |
| DM | 2024-03-11 | 2024-03-07+ | JBIO | Eldridge George A | SEE REMARKS | S - Sale+OE | $25.03 | -25.9K | 1,960 | -93% | -$649.2K |
| D | 2024-02-27 | 2024-02-23 | JBIO | Gillies Hunter | Chief MEDICAL Off | M - OptEx | $1.74 | +511 | 3,762 | +16% | +$889.14 |
| D | 2024-02-27 | 2024-02-23 | JBIO | Gillies Hunter | Chief MEDICAL Off | S - Sale+OE | $19.50 | -511 | 3,251 | -14% | -$9,964 |
| DM | 2024-02-22 | 2024-02-20 | JBIO | Gillies Hunter | Chief MEDICAL Off | S - Sale+OE | $20.23 | -3,489 | 3,251 | -52% | -$70.6K |
| D | 2024-02-22 | 2024-02-20 | JBIO | Gillies Hunter | Chief MEDICAL Off | M - OptEx | $1.74 | +3,489 | 6,740 | +107% | +$6,071 |
| DM | 2024-02-07 | 2024-02-05 | JBIO | NIVEN RALPH | CSO | M - OptEx | $2.02 | +4,600 | 6,209 | +286% | +$9,284 |
| D | 2024-02-07 | 2024-02-05 | JBIO | NIVEN RALPH | CSO | S - Sale+OE | $17.45 | -4,600 | 1,609 | -74% | -$80.3K |
| D | 2024-01-19 | 2024-01-17 | JBIO | Gillies Hunter | Chief MEDICAL Off | M - OptEx | $1.74 | +4,000 | 7,251 | +123% | +$6,960 |
| D | 2024-01-19 | 2024-01-17 | JBIO | Gillies Hunter | Chief MEDICAL Off | S - Sale+OE | $19.50 | -4,000 | 3,251 | -55% | -$78.0K |
| DM | 2024-01-08 | 2024-01-05 | JBIO | NIVEN RALPH | CSO | M - OptEx | $2.02 | +4,600 | 6,209 | +286% | +$9,284 |
| DM | 2024-01-08 | 2024-01-05 | JBIO | NIVEN RALPH | CSO | S - Sale+OE | $19.15 | -4,600 | 1,609 | -74% | -$88.1K |
| D | 2023-12-29 | 2023-12-27 | JBIO | Gillies Hunter | Chief MEDICAL Off | S - Sale+OE | $24.50 | -125 | 3,251 | -4% | -$3,062 |
| D | 2023-12-29 | 2023-12-27 | JBIO | Gillies Hunter | Chief MEDICAL Off | M - OptEx | $2.14 | +125 | 3,376 | +4% | +$267.50 |
| D | 2023-12-22 | 2023-12-13 | JBIO | Gillies Hunter | Chief MEDICAL Off | M - OptEx | $1.74 | +4,000 | 7,251 | +123% | +$6,960 |
| D | 2023-12-22 | 2023-12-20 | JBIO | Gillies Hunter | Chief MEDICAL Off | S - Sale+OE | $19.50 | -4,000 | 3,251 | -55% | -$78.0K |
| DM | 2023-12-15 | 2023-12-13+ | JBIO | Gillies Hunter | Chief MEDICAL Off | M - OptEx | $1.74 | +12.0K | 5,354 | New | +$20.9K |
| DM | 2023-12-15 | 2023-12-13+ | JBIO | Gillies Hunter | Chief MEDICAL Off | S - Sale+OE | $19.50 | -12.0K | 3,251 | -79% | -$234.0K |
| DM | 2023-12-07 | 2023-12-06 | JBIO | Dake Benjamin T | SEE REMARKS | M - OptEx | $2.05 | +10.3K | 11.6K | +797% | +$21.0K |
| D | 2023-12-07 | 2023-12-06 | JBIO | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $16.11 | -10.3K | 1,291 | -89% | -$165.7K |
| DM | 2023-12-07 | 2023-12-05 | JBIO | NIVEN RALPH | CSO | M - OptEx | $2.02 | +4,600 | 3,009 | New | +$9,284 |
| D | 2023-12-07 | 2023-12-05 | JBIO | NIVEN RALPH | CSO | S - Sale+OE | $16.30 | -4,600 | 1,609 | -74% | -$75.0K |
| DM | 2023-11-29 | 2023-11-27 | JBIO | Dake Benjamin T | SEE REMARKS | M - OptEx | $2.06 | +12.5K | 3,704 | New | +$25.8K |
| D | 2023-11-29 | 2023-11-27 | JBIO | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $16.24 | -12.5K | 1,291 | -91% | -$203.3K |
| DM | 2023-11-27 | 2023-11-22+ | JBIO | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $15.37 | -14.4K | 1,291 | -92% | -$220.9K |
| DM | 2023-11-27 | 2023-11-22+ | JBIO | Dake Benjamin T | SEE REMARKS | M - OptEx | $2.07 | +14.4K | 6,281 | New | +$29.8K |
| DM | 2023-11-27 | 2023-11-22 | JBIO | NIVEN RALPH | CSO | M - OptEx | $2.02 | +13.8K | 5,809 | New | +$27.9K |
| D | 2023-11-27 | 2023-11-22 | JBIO | NIVEN RALPH | CSO | S - Sale+OE | $15.00 | -13.8K | 1,609 | -90% | -$207.0K |
| 2023-11-03 | 2023-11-01 | JBIO | Verwijs Marinus | CTO | S - Sale | $10.46 | -970 | 0 | -100% | -$10.1K | |
| 2023-11-03 | 2023-11-01 | JBIO | NOYES TIMOTHY P | CEO, Dir | S - Sale | $10.42 | -1,092 | 0 | -100% | -$11.4K | |
| DM | 2023-09-08 | 2023-09-06+ | JBIO | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $15.06 | -3,961 | 1,291 | -75% | -$59.7K |
| DM | 2023-09-08 | 2023-09-06+ | JBIO | Dake Benjamin T | SEE REMARKS | M - OptEx | $1.90 | +3,961 | 3,704 | New | +$7,511 |
| DM | 2023-08-09 | 2023-08-07 | JBIO | Dake Benjamin T | SEE REMARKS | M - OptEx | $2.05 | +10.3K | 11.6K | +797% | +$21.0K |
| DM | 2023-08-09 | 2023-08-07 | JBIO | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $15.52 | -10.3K | 1,291 | -89% | -$159.6K |
| D | 2023-08-01 | 2023-07-28 | JBIO | NOYES TIMOTHY P | CEO, Dir | M - OptEx | $2.14 | +5,478 | 5,478 | New | +$11.7K |
| D | 2023-08-01 | 2023-07-28 | JBIO | NOYES TIMOTHY P | CEO, Dir | S - Sale+OE | $18.00 | -5,478 | 0 | -100% | -$98.6K |
| D | 2023-07-19 | 2023-07-17 | JBIO | NOYES TIMOTHY P | CEO, Dir | S - Sale+OE | $18.11 | -4,522 | 0 | -100% | -$81.9K |
| D | 2023-07-19 | 2023-07-17 | JBIO | NOYES TIMOTHY P | CEO, Dir | M - OptEx | $2.14 | +4,522 | 4,522 | New | +$9,677 |
| DM | 2023-07-07 | 2023-07-05 | JBIO | NIVEN RALPH | CSO | M - OptEx | $2.02 | +2,250 | 3,859 | +140% | +$4,555 |
| DM | 2023-07-07 | 2023-07-05 | JBIO | NIVEN RALPH | CSO | S - Sale+OE | $17.29 | -2,250 | 1,609 | -58% | -$38.9K |
| DM | 2023-07-07 | 2023-07-06 | JBIO | Dake Benjamin T | SEE REMARKS | M - OptEx | $2.05 | +10.3K | 11.6K | +797% | +$21.0K |
| D | 2023-07-07 | 2023-07-06 | JBIO | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $16.66 | -10.3K | 1,291 | -89% | -$171.3K |
| D | 2023-07-05 | 2023-07-03 | JBIO | NOYES TIMOTHY P | CEO, Dir | M - OptEx | $2.14 | +10.0K | 10.0K | New | +$21.4K |
| D | 2023-07-05 | 2023-07-03 | JBIO | NOYES TIMOTHY P | CEO, Dir | S - Sale+OE | $18.00 | -10.0K | 0 | -100% | -$180.0K |
| DM | 2023-06-08 | 2023-06-06 | JBIO | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $16.28 | -10.3K | 1,291 | -89% | -$167.4K |
Purchase Sale Sale after option exercise All abbreviations